The alliance of sphingosine-1-phosphate and its receptors in immunity
Open accessThe DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Abstract
Sphingosine-1-phosphate (S1P) is a biologically active metabolite of plasma-membrane sphingolipids that is essential for immune-cell trafficking. Its concentration is increased in many inflammatory conditions, such as asthma and autoimmunity. Much of the immune function of S1P results from the engagement of a family of G-protein-coupled receptors (S1PR1-S1PR5). Recent findings on the role of S1P in immunosurveillance, the discovery of regulatory mechanisms in S1P-mediated immune-cell trafficking and new advances in understanding the mechanism by which S1P affects immune-cell function indicate that the alliance between S1P and its receptors has a fundamental role in immunity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The multiple biological activities of S1P are mediated by five distinct G protein-coupled receptors (S1PR1–5), which are differently expressed in various tissues163.”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [163]
In the citing paper
“Sphingosine receptors play an important role in innate immune responses (120), and sphingosine analogs have shown potential for controlling the cytokine storm caused by influenza virus (95).”
From Into the Eye of the Cytokine Storm (2012) · cites this paper as [120]
Citations
Cites
1 retracted
Melendez, A. J., & Khaw, A. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110944200 · Cited by 159
RetractedPrinciples of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333 · cited 1×
“Two sphingosine kinases ( SPHK1 and SPHK2 ) then phosphorylate sphingosine to generate the lysosphingolipid sphingosine-1-phosphate (S1P”
BackgroundLymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004) · Nature · doi:10.1038/nature02284 · Cited by 2,581
Self-citationThe Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors
Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E., Baumruker, T., Hiestand, P., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200176200 · Cited by 1,504 · cited 1×
“A breakthrough in the understanding of its mechanism, together with a link to S1PR signalling, came with the realization that FTY720 is a sphingosine analogue that could be phosphorylated by SPHKs to produce a S1PR ligan”
BackgroundCD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs
Shiow, L. R., Rosen, D. B., Brdičková, N., Xu, Y., An, J., Lanier, L. L., Cyster, J. G., & Matloubian, M. (2006) · Nature · doi:10.1038/nature04606 · Cited by 1,189
Liu, Y., Wada, R., Yamashita, T., Mi, Y., Deng, C.-X., Hobson, J. P., Rosenfeldt, H. M., Nava, V. E., Chae, S.-S., Lee, M.-J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10905 · Cited by 1,149 · cited 1×
“Further support is provided by the well-documented role of S1PR1 in regulating endothelial-cell organization during developmen”
BackgroundSelf-citationOral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
Kappos, L., Antel, J., Comi, G., Montalban, X., O'Connor, P., Polman, C. H., Haas, T., Korn, A. A., Karlsson, G., & Radue, E. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052643 · Cited by 1,054 · cited 1×
“By contrast, treatment of patients with relapsing–remitting multiple sclerosis with considerably lower doses of FTY720 alone has proven to be beneficia”
ResultPromotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate
Pappu, R., Schwab, S. R., Cornelissen, I., Pereira, J. P., Regard, J. B., Xu, Y., Camerer, E., Zheng, Y.-W., Huang, Y., Cyster, J. G., et al. (2007) · Science · doi:10.1126/science.1139221 · Cited by 877
Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients
Schwab, S. R., Pereira, J. P., Matloubian, M., Xu, Y., Huang, Y., & Cyster, J. G. (2005) · Science · doi:10.1126/science.1113640 · Cited by 787 · cited 1×
“Notable exceptions are the blood, where S1P levels are in the low-micromolar range and are mainly contributed by erythrocytes, and the lymph, where S1P levels are in the hundred-nanomolar rang”
BackgroundEssential Role for Sphingosine Kinases in Neural and Vascular Development
Mizugishi, K., Yamashita, T., Olivera, A., Miller, G. F., Spiegel, S., & Proia, R. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.11113-11121.2005 · Cited by 742 · cited 1×
“More specifically, deletion of the genes that encode both kinases is embryonic lethal and results in embryos lacking S1”
BackgroundSelf-citation
Cited by
Items 401–500 of 634
Crosslink between lipids and acute uveitis: a lipidomic analysis
Wang, H., Wang, Y., Zhang, Y., Wang, J., Xiong, S., & Sun, Q. (2018) · International Journal of Ophthalmology · doi:10.18240/ijo.2018.05.05 · Cited by 17
Imaging the Bone-Immune Cell Interaction in Bone Destruction
Hasegawa, T., Kikuta, J., & Ishii, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00596 · Cited by 19
“S1P signaling involves five receptors, designated S1PR1 to S1PR5 (14, 15); osteoclast precursors in the bonemarrow express both S1PR1 and S1PR2.”
BackgroundRole of sphingolipids in the pathogenesis of intrahepatic cholestasis
Mikucka-Niczyporuk, A., Pierzyński, P., Lemancewicz, A., Kosinski, P. D., Charkiewicz, K., Knaś, M., Kacerovský, M., Błachnio-Zabielska, A. U., & Laudański, P. (2019) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2019.106399 · Cited by 17
The role of sphingosine 1-phosphate in immunity and sepsis.
Gräler, M. H. (2012) · Europe PMC (PubMed Central) · Cited by 25
Ceramides in the Pathophysiology of the Anterior Segment of the Eye
Robciuc, A., Hyötyläinen, T., Jauhiainen, M., & Holopainen, J. M. (2013) · Current Eye Research · doi:10.3109/02713683.2013.810273 · Cited by 18
Usage of Sphingosine Kinase Isoforms in Mast Cells Is Species and/or Cell Type Determined
Dillahunt, S., Sargent, J. L., Suzuki, R., Proia, R. L., Gilfillan, A. M., Rivera, J., & Olivera, A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201503 · Cited by 22
“S1P is a pleiotropic lipid mediator of diverse biological functions, including the regulation of vascular permeability and vascular tone (2, 3), modulation of immune cell trafficking and function (4, 5), and regulation of numerous disease processes (6–10).”
BackgroundSelf-citationMoberly, J. B., Rohatagi, S., Zahir, H., Hsu, C., Noveck, R. J., & Truitt, K. E. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270011408728 · Cited by 18
“Nadir, % of baseline 75 ± 9 62 ± 7 44 ± 13 18 ± 3 11 ± 6 Time to nadir, h 6 (1-36) 24 (6-36) 12 (4-24) 16 (3-48) 24 (6-48)”
Novel S1P1 receptor agonists – Part 5: From amino-to alkoxy-pyridines
Bolli, M. H., Lescop, C., Birker, M., de Kanter, R., Hess, P., Kohl, C., Nayler, O., Rey, M., Sieber, P., Velker, J., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.020 · Cited by 17
Xiao, S., & Yang, J. P. (2018) · Investigational New Drugs · doi:10.1007/s10637-018-0618-5 · Cited by 18
Bolli, M. H., Velker, J., Müller, C., Mathys, B., Birker, M., Bravo, R., Bur, D., de Kanter, R., Hess, P., Kohl, C., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401456d · Cited by 18
The role of isoflavones in augmenting the effects of radiotherapy
Ivashkevich, A. N. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.800562 · Cited by 16
Memo Has a Novel Role in S1P Signaling and Crucial for Vascular Development
Kondo, S., Bottos, A., Allegood, J. C., Masson, R., Maurer, F. G., Genoud, C., Kaeser, P., Huwiler, A., Murakami, M., Spiegel, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094114 · Cited by 18
“S1P has a crucial role in many physiological processes including vascular development and lymphocyte trafficking[7,8].”
Sphingolipids and Epoxidized Lipid Metabolites in the Control of Gut Immunosurveillance and Allergy
Kunisawa, J., & Kiyono, H. (2016) · Frontiers in Nutrition · doi:10.3389/fnut.2016.00003 · Cited by 15
“Sphingosine 1-phosphate (S1P) is a type of sphingolipid that is a focus of attention as a lipid mediator involved in immunomodulation (29, 30).”
BackgroundSphingolipids and Innate Immunity: A New Approach to Infection in the Post-Antibiotic Era?
Baker, J. E., Boudreau, R. M., Seitz, A. P., Caldwell, C. C., Gulbins, E., & Edwards, M. J. (2018) · Surgical Infections · doi:10.1089/sur.2018.187 · Cited by 19
“Binding of S1P to its receptor effects chemotaxis, differentiation, and effector cell response [63].”
Burow, P., Klapperstück, M., & Markwárdt, F. (2015) · Biophysical Journal · doi:10.1016/j.bpj.2014.11.2410 · Cited by 16
Emeterio, C. L. S., Hymel, L. A., Turner, T., Ogle, M. E., Pendleton, E. G., York, W. Y., Olingy, C. E., Liu, A. Y., Lim, H. S., Sulchek, T., et al. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.650289 · Cited by 16
Tolksdorf, C., Moritz, E., Wolf, R. H., Meyer, U., Marx, S., Bien-Möller, S., Garscha, U., Jedlitschky, G., & Rauch, B. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810278 · Cited by 19
“S1P mediates its effect after binding to the S1PR via different α units (αi, αq, and α12/13) [33].”
BackgroundFragile privileges: autoimmunity in brain and eye
Wekerle, H., & Sun, D. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.149 · Cited by 16
Li, C., Chi, X. X., Xie, W., Strong, J. A., Zhang, J.-M., & Nicol, G. D. (2012) · Journal of Neurophysiology · doi:10.1152/jn.00825.2011 · Cited by 16
Sphingosine Kinase-1/sphingosine 1-phosphate pathway in diabetic nephropathy
Yanhui, D., Lan, T., Juan, H., & Heqing, H. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20133344 · Cited by 16
Kulinski, J. M., Proia, R. L., Larson, E. M., Metcalfe, D. D., & Olivera, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051279 · Cited by 19
“Various S1P receptors modulate chemotaxis in a variety of cell types [33].”
BackgroundSelf-citationXiao, L., Zhu, L., Yang, S., Lei, D., Xiao, Y., & Peng, B. (2014) · Journal of Endodontics · doi:10.1016/j.joen.2014.10.010 · Cited by 15
Extracellular molecules in hematopoietic stem cell mobilisation
Bendall, L. J. (2016) · International Journal of Hematology · doi:10.1007/s12185-016-2123-y · Cited by 17
Ceramide synthase 2 facilitates S1P‐dependent egress of thymocytes into the circulation in mice
Rieck, M., Kremser, C., Jobin, K., Mettke, E., Kurts, C., Gräler, M. H., Willecke, K., & Kolanus, W. (2017) · European Journal of Immunology · doi:10.1002/eji.201646623 · Cited by 15
Swamy, M. M. M., Murai, Y., Ohno, Y., Jojima, K., Kihara, A., Mitsutake, S., Igarashi, Y., Yu, J., Yao, M., Suga, Y., et al. (2018) · Chemical Communications · doi:10.1039/c8cc05595e · Cited by 16
Martínez-Morales, J. C., Romero‐Ávila, M. T., Reyes‐Cruz, G., & García-Sáinz, J. A. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.121.000429 · Cited by 16
“This receptor is of particular interest because it regulates lymphocyte egress from the lymph nodes, which impacts immunity, particularly in some autoimmune diseases (P (cid:1) erez-Jeldres et al., 2021; Rivera et al., 2008).”
BackgroundConstantinescu, V. A., Akgün, K., & Ziemssen, T. (2022) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2022.2138330 · Cited by 16
“from the periphery to take part in the inflammatory setting [26].”
BackgroundInfluentialImmunoregulatory Effects of Interferon-β in Suppression of Th17 cells
Pennell, L. M., & Fish, E. N. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2013.0088 · Cited by 14
Voelkel, N. F., & Spiegel, S. (2009) · Immunology and Cell Biology · doi:10.1038/icb.2009.45 · Cited by 16
Topical Application of Fingolimod Perturbs Cutaneous Inflammation
Sun, W. Y., Dimasi, D. P., Pitman, M. R., Zhuang, Y., Heddle, R. J., Pitson, S. M., Grimbaldeston, M. A., & Bonder, C. S. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501510 · Cited by 16
“Determined to address this question, we turned to an in situ assay using the human VeraVec endothelial cells as the representative of an S1P-producing cell within the ear (30).”
MethodThieme, M., Zillikens, D., & Sadik, C. D. (2017) · Experimental Dermatology · doi:10.1111/exd.13174 · Cited by 14
Yagci, Z. B., Esvap, E., Özkara, H. A., Ülgen, K. Ö., & Özkırımlı, E. (2018) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2018.09.004 · Cited by 16
Gowda, D., Ohno, M., Gowda, S. G. B., Chiba, H., Shingai, M., Kida, H., & Hui, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-99765-0 · Cited by 17
Lymphocyte Modulation with FTY720 Improves Hemorrhagic Shock Survival in Swine
Hawksworth, J. S., Graybill, J. C., Brown, T. S., Wallace, S. M., Davis, T. A., Tadaki, D. K., & Elster, E. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034224 · Cited by 14
“FTY720, an immunomodulator recently approved for the treatment of multiple sclerosis, sequestrates lymphocytes to secondary lymphoid organs and reduces circulatory lymphocytes PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e34224 by targeting receptors for sphingosine 1-phosphate (S1P) [10,11,12].”
InfluentialOlivera, A., Kitamura, Y., Wright, L. D., Allende, M. L., Chen, W., Kaneko-Goto, T., Yoshihara, Y., Proia, R. L., & Rivera, J. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0313163 · Cited by 16
Self-citationFluorescence-based rapid measurement of sphingosine-1-phosphate transport activity in erythrocytes
Kobayashi, N., Otsuka, M., Yamaguchi, A., & Nishi, T. (2016) · Journal of Lipid Research · doi:10.1194/jlr.d071068 · Cited by 15
“org S1P recruits lymphocytes from the thymus and secondary lymphoid organs to the circulatory system by activating S1P receptors on lymphocytes (5).”
BackgroundDash, R. P., Rais, R., & Srinivas, N. R. (2017) · Xenobiotica · doi:10.1080/00498254.2017.1329568 · Cited by 14
“…of sphingosine by two intracellular sphingosine kinase isoforms (SphK1, SphK2) or through the extracellular hydrolysis of sphingosyl phosphorylcholine by autotoxin and degraded by sphingosine lyases and sphingosine phosphatases (Clair et al., 2003; Rivera et al., 2008; Spiegel & Milstien, 2003).”
BackgroundRole of S1P/S1PR3 axis in release of CCL20 from human bronchial epithelial cells
Kawa, Y., Nagano, T., Yoshizaki, A., Dokuni, R., Katsurada, M., Terashita, T., Yasuda, Y., Umezawa, K., Yamamoto, M., Kamiryo, H., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203211 · Cited by 14
Sjödin, M. O. D., Checa, A., Yang, M., Dahlén, S., Wheelock, Å. M., Eklúnd, A., Grünewald, J., & Wheelock, C. E. (2018) · Respiratory Research · doi:10.1186/s12931-018-0939-0 · Cited by 15
Mast cells in innate and adaptive immunity to infection
Palker, T. J., Dong, G., & Leitner, W. W. (2009) · European Journal of Immunology · doi:10.1002/eji.200990325 · Cited by 14
N ‐Acyl Amides from Neisseria meningitidis and Their Role in Sphingosine Receptor Signaling
Cho, W., York, A. G., Wang, R., Wyche, T. P., Piizzi, G., Flavell, R. A., & Crawford, J. M. (2022) · ChemBioChem · doi:10.1002/cbic.202200490 · Cited by 13
Metabolism of sphingadiene and characterization of the sphingadiene-producing enzyme FADS3
Jojima, K., & Kihara, A. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2023.159335 · Cited by 17
Ishii, T., Kikuta, J., Kubo, A., & Ishii, M. (2010) · IBMS BoneKEy · doi:10.1138/20100459 · Cited by 13
“Mammals possess five types of S1P receptors, S1P1 to S1P5, and macrophage-monocyte lineage cells express S1P1 and S1P2 (27-29).”
BackgroundInfluentialDifferential role of adenosine signaling cascade in acute and chronic pain
Adebiyi, M. G., Manalo, J. M., Kellems, R. E., & Xia, Y. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134483 · Cited by 15
Ziegler, A. C., Müller, T., & Gräler, M. H. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109849 · Cited by 17
Lee, D., Kim, J. ‐., Choi, S., Cha, J., Bak, E., & Yoo, Y. (2016) · Journal of Periodontal Research · doi:10.1111/jre.12366 · Cited by 13
“In contrast, high S1P levels are maintained in the blood, as vascular endothelial cells exposed to shear laminar stress and erythrocytes do not express S1P lyase or S1P phosphatases (1,5).”
BackgroundRole of sphingosine-1-phosphate mediated signalling in systemic lupus erythematosus
Tian, J., Huang, T., Chang, S., Wang, Y., Fan, W., He, J., Wang, J., Yang, J. Y., Kang, J., & Zhou, Y. (2021) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2021.106584 · Cited by 14
Martín‐Hernández, D., Muñoz‐López, M., Tendilla‐Beltrán, H., Caso, J. R., García‐Bueno, B., Menchen, L. A., & Leza, J. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612634 · Cited by 16
Morquecho‐León, M. A., Bazúa‐Valenti, S., Romero‐Ávila, M. T., & García-Sáinz, J. A. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.11.002 · Cited by 12
Fingolimod affects gene expression profile associated with LPS-induced memory impairment
Omidbakhsh, R., Rajabli, B., Nasoohi, S., Khallaghi, B., Mohamed, Z., Naidu, M. K., Ahmadiani, A., & Dargahi, L. (2014) · Experimental Brain Research · doi:10.1007/s00221-014-4052-4 · Cited by 13
“(Rivera et al. 2008).”
Liao, C., Barrow, F., Venkatesan, N., Nakao, Y., Mauer, A. S., Fredrickson, G., Song, M. J., Sehrawat, T. S., Dasgupta, D., Graham, R. P., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1130184 · Cited by 12
“In patients with relapsing multiple sclerosis, administration of low dose FTY720 and subsequent blockage of S1P-mediated T cell egress has shown beneficial disease outcomes and fewer side effects (37).”
BackgroundShirmanova, M. V. (2014) · Journal of Analytical & Bioanalytical Techniques · doi:10.4172/2155-9872.s1-008 · Cited by 12
Differential expression of innate immunity regulation genes in chronic HIV-1 infected adults
Peng, X., Sun, T., Yao, P., Chen, B., Lu, X., Han, D., & Wu, N. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154871 · Cited by 11
Dziak, R. (2013) · Immunological Investigations · doi:10.3109/08820139.2013.823804 · Cited by 12
“Likewise, there are a number of studies that suggest that the biological effect of S1P on cells is regulated by the relative level of expression of different S1PRs on immune cells (Rivera et al., 2008).”
InfluentialoxLDL and eLDL Induced Membrane Microdomains in Human Macrophages
Wallner, S., Grandl, M., Liebisch, G., Peer, M., Orsó, E., Sigrüener, A., Sobota, A., & Schmitz, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166798 · Cited by 12
Fukuzaki, Y., Faustino, J. V., Lecuyer, M., Rayasam, A., & Vexler, Z. S. (2023) · iScience · doi:10.1016/j.isci.2023.106340 · Cited by 11
Advances in the composition, efficacy, and mimicking of human milk phospholipids
Wang, Y., Liu, Q., Liu, Y., Qiao, W., Zhao, J., Cao, H., Liu, Y. C., & Chen, L. (2024) · Food & Function · doi:10.1039/d4fo00539b · Cited by 13
Halilbasic, E., Fuerst, E., Heiden, D., Japtok, L., Diesner, S. C., Trauner, M., Kulu, A., Jaksch, P., Höetzenecker, K., Kleuser, B., et al. (2020) · Nutrients · doi:10.3390/nu12030765 · Cited by 12
“It is well established that in most cells, ceramide is metabolized to sphingosine (SPH) and subsequently to S1P [7].”
BackgroundOverholt, K. J., Krog, J., Zanoni, I., & Bryson, B. D. (2021) · iScience · doi:10.1016/j.isci.2021.102738 · Cited by 11
“suppression of the S1PR1 cognate ligand S1P1 decreased mortality rates during influenza infection in mice [41, 42, 52].”
BackgroundLin, S. M., Pandruvada, S. N. M., & Yu, H. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112060 · Cited by 11
“However, the constitution levels of S1P in most tissues are very low (10–30 nM) because S1P can be degraded either by S1P lyase or dephosphorylated by S1P phosphatase [2,4].”
BackgroundNi, Q., Yuan, B., Liu, T., Lan, F., Luo, X., Lu, X., Huang, P., Dai, L., Jin, X., & Yin, H. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.03.004 · Cited by 11
Novel S1P 1 receptor agonists – Part 4: Alkylaminomethyl substituted aryl head groups
Lescop, C., Müller, C., Mathys, B., Birker, M., de Kanter, R., Kohl, C., Hess, P., Nayler, O., Rey, M., Sieber, P., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.048 · Cited by 12
SGPL1321 mutation: one main trigger for invasiveness of pediatric alveolar rhabdomyosarcoma
Adamus, A. L., Engel, N., & Seitz, G. (2019) · Cancer Gene Therapy · doi:10.1038/s41417-019-0132-8 · Cited by 11
Annabi, B., Chokor, R., & Lamy, S. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s62717 · Cited by 11
“Recent findings on the role of S1P in immunosurveillance support regulatory mechanisms in S1P-mediated immune-cell trafficking and suggest that any perturbance in the interactions between S1P and its receptors may affect immunity.(9) Recently the anti-inflammatory activity of plant and dietderived compounds, most belo…”
Sphingosine 1‐Phosphate (S1P) Signaling and the Vasculature
Waeber, C. (2013) · Wiley eBooks · doi:10.1002/9781118531426.ch15 · Cited by 11
Adamus, A. L., Ali, I., Vasileiadis, V., Al-Hileh, L., Lisec, J., Frank, M., Seitz, G., & Engel, N. (2021) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-021-03299-x · Cited by 10
Innate Immune Response and Epigenetic Regulation: A Closely Intertwined Tale in Inflammation
Jawale, D., Khandibharad, S., & Singh, S. (2024) · Advanced Biology · doi:10.1002/adbi.202400278 · Cited by 17
Amphiphilic degradable polymers for immobilization and sustained delivery of sphingosine 1-phosphate
Zhang, J., & Song, J. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2014.02.051 · Cited by 10
Asano, M., Nakamura, T., Sekiguchi, Y., Mizuno, Y., YAMAGUCHI, T. J., Tamaki, K., Shimozato, T., Doi-Komuro, H., Kagari, T., Tomisato, W., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.03.067 · Cited by 10
The Sphingosine 1-Phosphate Axis: an Emerging Therapeutic Opportunity for Endometriosis
Zhang, F., & Lu, Y. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01167-2 · Cited by 14
“T cells develop in the thymus, and once they mature, they would exit the thymus by expressing S1P1 to sense the gradient of S1P between tissue and lymphatic fluid and blood [96].”
BackgroundAltered Leukocyte Sphingolipid Pathway in Breast Cancer
Maia, L. P., Santos, P. D. S., Alves, P. T., Rodrigues, C., Araújo, T. G., Maia, Y. C. D. P., Câmara, A., Santos, D. W., & Goulart, L. R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122521 · Cited by 11
“Dendritic cells express all five receptors, whereas T cells express S1PR1 and 4, B cell express S1PR1 and 3, macrophages express S1PR1 and 2 [17], and eosinophil express S1PR1, 2, and 3 [18].”
BackgroundHashizume‐Takizawa, T., Shibata, N., Kurashima, Y., Kiyono, H., Kurita‐Ochiai, T., & Fujihashi, K. (2019) · International Immunology · doi:10.1093/intimm/dxz029 · Cited by 10
Reduction of Sphingosine Kinase 1 Phosphorylation and Activity in Plasmodium-Infected Erythrocytes
Sah, R. K., Pati, S., Saini, M., Boopathi, P. A., Kochar, S. K., Kochar, D. K., Das, A., & Singh, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00080 · Cited by 9
Montarolo, F., Martire, S., Marnetto, F., Valentino, P., Valverde, S., Capobianco, M. A. N., & Bertolotto, A. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44030083 · Cited by 10
“The immune-modulatory properties of selective agonists for S1P receptors involve the retention of T and B lymphocytes in secondary lymphoid organs through the internalization of the S1P1 present on their surface, thus preventing their recirculation to the CNS [6].”
BackgroundPerry, T., Masand, N., Vrzalikova, K., Pugh, M., Wei, W., Hollows, R. J., Bouchalová, K., Nohtani, M., Fennell, É., Bouchal, J., et al. (2024) · Cancers · doi:10.3390/cancers16030574 · Cited by 12
“S1PRs are G-protein coupled receptors that have partially convergent or antithetic effects [25–27].”
BackgroundLinking Lipid Metabolism and Immune Function: New Insights into Chronic Respiratory Diseases
Kotlyarov, S. N. (2025) · Pathophysiology · doi:10.3390/pathophysiology32020026 · Cited by 11
Han, T., Wu, Z., Zhu, J. W., Kou, Y., Li, J., & Deng, Y. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.683032 · Cited by 13
“S1PR5 encodes a G-protein-coupled receptor which is reported to be highly relevant to CREB activation (Rivera et al., 2008; Wang et al., 2020).”
BackgroundHengst, J. A., Nduwumwami, A. J., & Yun, J. K. (2022) · Cancers · doi:10.3390/cancers14215182 · Cited by 9
“To this end, S1P binds to and activates a cohort of five cell surface receptors (S1PR1S1PR5; [29]).”
BackgroundTanturovska, B. S., Živković, A., Imeri, F., Homann, T., Kleuser, B., Stark, H., & Huwiler, A. (2021) · Molecules · doi:10.3390/molecules26175134 · Cited by 9
“In environments with high levels of S1P, such as the blood, S1P1 is internalized and is not detectable at the surfaces of T cells, which allows homing in secondary lymphoid tissues [8].”
BackgroundAnwar, M., Amin, M. R., Ragunathrao, V. A. B., Matsche, J., Karginov, A. V., Minshall, R. D., Mo, G. C. H., Komarova, Y. A., & Mehta, D. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202006021 · Cited by 11
Pharmacokinetics of S1P receptor modulators in the treatment of ulcerative colitis
Vieujean, S., & Peyrin‐Biroulet, L. (2024) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2024.2402931 · Cited by 8
“S1PR1 are expressed by T cells, B cells, macrophages, mast cells, dendritic and natural killer (NK) cells, while S1PR5 are expressed by dendritic cells and NK cells [8,29].”
Choe, K., Ahmad, R., Kang, M. H., Lee, H. J., Ahmad, S., Park, T. J., & Kim, M. O. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02485-5 · Cited by 11
“It regulates cellular processes such as proliferation, migration, inflammatory responses, vascular and immune system modulation, and apoptosis inhibition [9].”
Qiu, L., Jiang, H., Zhou, C., Tangadanchu, V. K. R., Wang, J., Huang, T., Gropler, R. J., Perlmutter, J. S., Benzinger, T. L. S., & Tu, Z. (2024) · Organic & Biomolecular Chemistry · doi:10.1039/d4ob00712c · Cited by 8
Biocomparison of Three Formulations of the S1P1 Receptor Modulator Ponesimod in Healthy Subjects
Juif, P., Hoch, M., D’Ambrosio, D., & Dingemanse, J. (2015) · Drugs in R&D · doi:10.1007/s40268-015-0095-7 · Cited by 8
Chiba, K., Maeda, Y., Seki, N., Kataoka, H., & Sugahara, K. (2014) · AIMS molecular science · doi:10.3934/molsci.2014.4.162 · Cited by 8
“S1P acts as a high affinity agonist to five related G-protein-coupled receptors, termed S1P1, S1P2, S1P3, S1P4, and S1P5 [22,23] and regulates various cellular processes that are important for immune responses and inflammation [24,25].”
BackgroundImplications of chemokine receptors and inflammatory lipids in cancer
Maghazachi, A. A., & Rolin, J. (2013) · ImmunoTargets and Therapy · doi:10.2147/itt.s32049 · Cited by 8
“The receptors are expressed in different patterns through the immune system.(11) Dendritic cells express all five receptors(25,26) and human natural killer (NK) cells express mRNA for all receptors except for S1PR2.”
InfluentialWollny, T., Wątek, M., Wnorowska, U., Piktel, E., Góźdź, S. S., Kurek, K., Wolak, P., Król, G., Żendzian‐Piotrowska, M., & Bucki, R. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-06865-y · Cited by 10
Lee, S. H., Lee, J. Y., Lim, K.-H., Lee, Y.-S., Kim, S., Choi, S., Cho, S.-H., Kim, J. S., & Koh, J. (2021) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2021.03.005 · Cited by 8
Azeez, O. I., Myburgh, J. G., Bosman, A.-M., Featherston, J., Sibeko-Matjila, K. P., Oosthuizen, M. C., & Chamunorwa, J. P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225073 · Cited by 9
“Sphingosine -1- phosphate (S1P)–the substrate of SGPP2, is a lipid-mediator involved in immune cell traficking and signaling, it is therefore a proinflammtory-mediator that is upregulated during inflammation [81, 82].”
BackgroundHashemi, E., Yoseph, E., Tsai, H., Moreno, M. A., Yeh, L.-H., Mehta, S. B., Kono, M., Proia, R. L., & Han, M. H. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01245-0 · Cited by 7
Self-citationKorbelik, M. (2014) · Journal of Analytical & Bioanalytical Techniques · doi:10.4172/2155-9872.s1-009 · Cited by 7
“Five known dedicated receptors for S1P (S1PRs) ubiquitously expressed on various cells including macrophages are well characterized [40].”
BackgroundPatho‐immunological mechanisms of atopic dermatitis: The role of the three major human microbiomes
Zhou, Z., Yang, J., Liu, Q., Gao, J., & Ji, W. (2024) · Scandinavian Journal of Immunology · doi:10.1111/sji.13403 · Cited by 7
“A higher level of circulating S1P promotes the Th2 response, leading to an increase in the population of Th2 and Th17 cells, as well as an increase in the M2/M1 macrophage ratio 88,93 (Figure 2).”
Novel Lipid Signaling Mediators for Mesenchymal Stem Cell Mobilization During Bone Repair
Selma, J. M., Das, A., Awojoodu, A. O., Wang, T. L., Kaushik, A. P., Cui, Q., Song, H. W., Ogle, M. E., Olingy, C. E., Pendleton, E. G., et al. (2018) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-018-0532-0 · Cited by 6
GPCR-mediated EGFR transactivation ameliorates skin toxicities induced by afatinib
Chen, L., You, Q., Lv, D., Li, S., & Zhang, S. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00774-6 · Cited by 7
Riese, J., Hähnel, C., Menz, J., Hannemann, M., Khabipov, A., Lührs, F., & Schulze, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1053490 · Cited by 7
“While S1PR1–3 are nearly ubiquitously expressed, S1PR4 expression is restricted to cells of hematopoietic origin (11).”
BackgroundCarolin, A., Yan, K., Bishop, C., Tang, B., Nguyen, W., Rawle, D. J., & Suhrbier, A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0302344 · Cited by 10
“Another group of cytokines/chemo-kines associated with increased disease severity (IL-2, IFNG, IL-17, CSF2, CCL5, CXCL8, CCL2 [11,102,103] showed slightly lower z scores for BA.1 infected lungs (Fig 4B).”
Quattropani, A., Sauer, W., Crosignani, S., Dorbais, J., Gerber, P., Gonzalez, J., Marin, D., Muzerelle, M., Beltran, F., Nichols, A. C., et al. (2015) · ChemMedChem · doi:10.1002/cmdc.201402557 · Cited by 7
Song, H. E., Lee, S. H., Kim, S. J., Kim, B., Yoo, H. J., & Koh, J. (2020) · Journal of Investigative Medicine · doi:10.1136/jim-2020-001322 · Cited by 7
Uhl, F. E., Vanherle, L., Matthes, F., & Meißner, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020866 · Cited by 9
Visualizing bone tissue in homeostatic and pathological conditions
Hasegawa, T., & Ishii, M. (2020) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.96.004 · Cited by 6
Metadata
- Authors
- Rivera, J., Proia, R. L., & Olivera, A.
- Affiliations
- National Institutes of Health (US)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (US)
- Corresponding author
- Rivera, Juan
- Venue
- Nature Reviews Immunology
- Published
- 2008-10
- Volume
- 8
- Issue
- 10
- Pages
- 753-763
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC2600775
- OpenAlex
- W1967802627
- Cited by
- 616
- References
- 108
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 18 · 2023: 30 · 2022: 26 · 2021: 38 · 2020: 30 · 2019: 40 · 2018: 37 · 2017: 34 · 2016: 41 · 2015: 36 · 2014: 46 · 2013: 46 · 2012: 58
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (Z01AR041155)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- sphingosine-1-phosphate, S1P receptors, G protein-coupled receptors, immune cell trafficking, immunomodulation, immune surveillance, immune cell function, inflammation, asthma, autoimmunity, sphingolipids
- MeSH terms
- Animals, Cell Movement, Chemotaxis, Dendritic Cells, Humans, Lymphocytes, Lysophospholipids, Macrophages, Mast Cells, Sphingosine, Signal Transduction, Receptors, Lysosphingolipid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.